Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: A report of three cases and a review of the literature

Bone Marrow Transplantation

Volumn 20, Issue 10, 1997, Pages 901-904

  Hovenga, S ^a   De Wolf, J Th M ^a   Klip, H ^a   Vellenga, E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autologous stem cell transplantation; Plasma cell leukemia

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0030831843     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700982     Document Type: Article

References (20)

1. Woodruff RK, Mulpas JS, Paxton AM, Lister TA. Plasma cell leukaemia (PCL). A report on 15 patients. Blood 1981; 52: 839-845.
2. Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Am J Med 1987; 83: 1062-1068.
3. Bernasconi C, Castelli G, Pagnucco G, Brusamolino E. Plasma cell leukaemia: a report on 15 patients. Eur J Haematol 1989; 43: 71-83.
4. Kosmo MA, Gale RP. Plasma cell leukemia. Semin Hematol 1987; 24: 202-208.
5. Dimopoulos MA, Palumho A, Delasalle KB, Alexanian R. Primary plasma cell leukemia. Br J Haematol 1994; 88: 754-759.
6. McElwain TJ, Powles RL. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 1983; ii: 822-824.
7. Suzuki M, Kawanchi K, Sugiyama H. Primary plasma cell leukaemia: a case report of successful responder to a combination of vincristine, doxorubicin and dexamethasone. Acta Hematol 1989; 62: 95-97.
8. Malhorta H, Dhabbar BN, Saikia TK et al. Ifosfamide in plasma cell leukemia: a report of two cases and review of the literature. Am J Hematol 1992; 40: 226-228.
9. Yamagata N, Shimazaki C, Goto H et al. IgE plasma cell leukaemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alfa. Am J Hematol 1994; 45: 262-264.
10. Osanto S, Muller HP, Schuit HRE. Primary plasma cell leukaemia. Acta Haematol 1983; 70: 122-129.
11. Montecucco C, Riccardi A, Merlini G, Ascari E. Complete remission in plasma cell leukaemia. Br J Haematol 1986; 62: 525-527.
12. Djaldetti M, Joshua H. Acute plasma cell leukaemia. Isr Med J 1961; 20: 109-114.
13. Pacilli L, Ferraro P, Cochi S. Plasma cell leukaemia. Tumori 1983; 69: 589-591.
14. Zawadski ZA, Kapadia S, Barnes AE. Leukemic myelomatosis (plasma cell leukaemia). Am J Clin Pathol 1978; 70: 605-611.
15. Corradini P, Voena C, Astolfi M et al. High dose sequential chemotherapy in MM: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 1994; 85: 1596-1602.
16. Yen KH, Lin MT, Tang JL et al. Long-term disease free survival after autologous bone marrow transplantation in a primary plasma cell leukaemia: detection of minimal residual disease in the transplant marrow by third-complementarity-determining region-specific probes. Br J Haematol 1995; 89: 914-916.
17. Björkstrand J, Ljungman P, Svensson H et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 1996; 88: 4711-4718.
18. Jagannath S, Vesole DH, Tricot G et al. Hemopoietic stem cell transplants for multiple myeloma. Oncology 1994; 8: 89-103.
19. Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-793.
20. Tricot G, Vesole DH, Jagannath S et al. Graft versus myeloma effect: proof of principle. Blood 1996; 87: 1196-1198.